Picture of Mendus AB (publ) logo

IMMU — Mendus AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Immunicum Q4 Loss For Period At SEK 47.6 Mln

Feb 18 (Reuters) - Immunicum AB  IMMUN.ST :
    * Q4 DILUTED LOSS PER SHARE 0.57 SEK
    * REG-IMMUNICUM AB (PUBL) ANNOUNCES YEAR-END RESULTS 2020
    * Q4 RESULT FOR PERIOD AMOUNTED TO KSEK -47,568 (19,409)*.

Source text for Eikon:  ID:nGNEbsspzw 
Further company coverage:  IMMUN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Mendus AB (publ)

See all news